Oncolytics Reports Update on Plannede Registration Program for REOLYSIN

By: via Benzinga
Oncolytics Biotech® Inc. (NASDAQ: ONCY) ("Oncolytics" or the "Company") today provided an update on its planned registration program for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.